SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors TG Therapeutics, Inc.
globenewswire.com
news
2022-06-05 00:00:00

NEW YORK, June 05, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of TG Therapeutics, Inc. ('TG Therapeutics' or the 'Company') (NASDAQ: TGTX).   Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether TG Therapeutics and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On November 30, 2021, TG Therapeutics issued a press release 'announc[ing] the U.
